BindingDB logo
myBDB logout

null

SMILES: Fc1cc(cc(F)c1N1CCN(Cc2ccc3c4NCCCc4c(=O)[nH]c3c2)CC1)C(=O)NC1CC1

InChI Key: InChIKey=QSDUGBPLSHIMHQ-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 419747   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Poly [ADP-ribose] polymerase 1


(Homo sapiens (Human))
BDBM419747
PNG
(US10464919, Example 85)
Show SMILES Fc1cc(cc(F)c1N1CCN(Cc2ccc3c4NCCCc4c(=O)[nH]c3c2)CC1)C(=O)NC1CC1
Show InChI InChI=1S/C27H29F2N5O2/c28-21-13-17(26(35)31-18-4-5-18)14-22(29)25(21)34-10-8-33(9-11-34)15-16-3-6-19-23(12-16)32-27(36)20-2-1-7-30-24(19)20/h3,6,12-14,18,30H,1-2,4-5,7-11,15H2,(H,31,35)(H,32,36)
PDB
MMDB

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.87n/an/an/an/an/an/a



Je Il Pharmaceutical Co., Ltd.

US Patent


Assay Description
The PARP-1 enzyme inhibitory activities of the compounds of the present invention were assayed in the following manner by use of a kit (cat. 80551) p...


US Patent US10464919 (2019)


BindingDB Entry DOI: 10.7270/Q2736T8M
More data for this
Ligand-Target Pair
Activated CDC42 kinase 1


(Homo sapiens (Human))
BDBM419747
PNG
(US10464919, Example 85)
Show SMILES Fc1cc(cc(F)c1N1CCN(Cc2ccc3c4NCCCc4c(=O)[nH]c3c2)CC1)C(=O)NC1CC1
Show InChI InChI=1S/C27H29F2N5O2/c28-21-13-17(26(35)31-18-4-5-18)14-22(29)25(21)34-10-8-33(9-11-34)15-16-3-6-19-23(12-16)32-27(36)20-2-1-7-30-24(19)20/h3,6,12-14,18,30H,1-2,4-5,7-11,15H2,(H,31,35)(H,32,36)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 10.3n/an/an/an/an/an/a



Je Il Pharmaceutical Co., Ltd.

US Patent


Assay Description
The tankyrase-1 or tankyrase-2 enzyme inhibitory activities of the compounds of the present invention were assayed in the following manner by use of ...


US Patent US10464919 (2019)


BindingDB Entry DOI: 10.7270/Q2736T8M
More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TNK1


(Homo sapiens (Human))
BDBM419747
PNG
(US10464919, Example 85)
Show SMILES Fc1cc(cc(F)c1N1CCN(Cc2ccc3c4NCCCc4c(=O)[nH]c3c2)CC1)C(=O)NC1CC1
Show InChI InChI=1S/C27H29F2N5O2/c28-21-13-17(26(35)31-18-4-5-18)14-22(29)25(21)34-10-8-33(9-11-34)15-16-3-6-19-23(12-16)32-27(36)20-2-1-7-30-24(19)20/h3,6,12-14,18,30H,1-2,4-5,7-11,15H2,(H,31,35)(H,32,36)
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 11.8n/an/an/an/an/an/a



Je Il Pharmaceutical Co., Ltd.

US Patent


Assay Description
The tankyrase-1 or tankyrase-2 enzyme inhibitory activities of the compounds of the present invention were assayed in the following manner by use of ...


US Patent US10464919 (2019)


BindingDB Entry DOI: 10.7270/Q2736T8M
More data for this
Ligand-Target Pair